Evidence map›Paper›PMID 41268684›Full record

ArticleAnnals of medicine2025

Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort study.

Wei Guo, Bolun Zhou, Qilin Huai, Ying Ji, Ying Chen, Huayu He, Liankui Han, Bangsheng Li, Junzheng Zhou, Fengwei Tan and 3 more

Abstract readMulticenter Study
In one paragraph

Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wei GuoDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Bolun ZhouDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Qilin HuaiDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Ying JiDepartment of Thoracic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.
Ying ChenDepartment of Thoracic Surgery, Yunnan Cancer Hospital, Kunming, People's Republic of China.
Huayu HeDepartment of Thoracic Surgery, Peking University Third Hospital, Beijing, People's Republic of China.
Liankui HanDepartment of Thoracic Surgery, Guizhou Provincial People's Hospital, Guizhou, People's Republic of China.
Bangsheng LiDepartment of Thoracic Surgery, Yunnan Cancer Hospital, Kunming, People's Republic of China.
Junzheng ZhouDepartment of Thoracic Surgery, Anyang Cancer Hospital, Anyang, People's Republic of China.
Fengwei TanDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Qi XueDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Shugeng GaoDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.ORCID 0000-0003-4211-552X
Jie HeDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the advancement of diagnostic technology and changes in living environment, the incidence of synchronous multiple primary lung cancer (sMPLC) is increasing. This study aims to investigate the impact of surgical timing on clinical outcomes.

methodsThis multi-institutional cohort study retrospectively enrolled 901 patients with bilateral sMPLC who underwent two surgeries from January 2017 to December 2022. Three different subgroups were determined based on the time interval between the 1

resultsFor the entire cohort, the median follow-up time from the second surgery was 49.2 months. The clinical outcomes of patients in Group-II were more favourable than those in Group-I and Group-III (log-rank, OS,

conclusionsFor patients with bilateral sMPLC, our research identified a potential correlation between the interval of subsequent surgeries and patient prognosis. We suggest that an interval of 90 to 180 days between surgeries may be the most beneficial.

Indexed as

Lung NeoplasmsNeoplasms, Multiple PrimaryAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPneumonectomyRetrospective StudiesTime FactorsTreatment OutcomeMultiple primary lung canceroverall survivalsurgerysynchronous

Identifiers

PMID41268684
PMCPMC12642896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.